The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake (HPV-Education)

January 20, 2026 updated by: Gizem Bilmez, Ufuk University

"Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"

Type of Study: This study was planned to be an observational study.

Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question[s] it aims to answer [is/are]:

H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.

H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests.

H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status.

Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
    • Ankara
      • Ankara, Ankara, Turkey (Türkiye), 06000
        • Recruiting
        • Ufuk University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being female
  • Women aged 18-35 years
  • Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
  • Having the technical equipment necessary to participate in a video interview
  • No diagnosis of HPV positivity
  • Not having received the HPV vaccine
  • Not having undergone HPV DNA/Pap smear testing in the past 5 years
  • No diagnosis of cervical cancer
  • Voluntary willingness to participate in the study
  • No diagnosis of a psychiatric disorder

Exclusion Criteria:

  • Being male
  • Having severe physical or cognitive impairments that prevent completing the questionnaire
  • Being under 18 years of age or over 35 years of age
  • Inability to speak or understand Turkish
  • Lack of technical equipment to participate in a video interview
  • Having a diagnosis of HPV positivity
  • Having received the HPV vaccine
  • Having undergone HPV DNA/Pap smear testing in the past 5 years
  • Having a diagnosis of cervical cancer
  • Having a diagnosed psychiatric disorder

Not agreeing to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Online Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.
Behavioral: Online Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.
Other: Contral Group
No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HPV Knowledge Score
Time Frame: Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)
Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.
Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained HPV Knowledge Score (Knowledge Retention)
Time Frame: Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.
Final follow-up (8 weeks after the first follow-up)
Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ufuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2026

Primary Completion (Estimated)

January 23, 2026

Study Completion (Estimated)

April 3, 2026

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

December 19, 2025

First Posted (Actual)

January 6, 2026

Study Record Updates

Last Update Posted (Actual)

January 22, 2026

Last Update Submitted That Met QC Criteria

January 20, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E-81182178-605-56406

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to privacy and confidentiality concerns of the participants, individual participant data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HPV Immunization Status

Clinical Trials on Online Education Intervention Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe